Do the Results of RE-SPECT ESUS Call for a Revision of the Embolic Stroke of Undetermined Source Definition?

被引：18
|
作者：
Paciaroni, Maurizio [1 ,2 ]
Kamel, Hooman [3 ,4 ]
机构：
[1] Univ Perugia, Santa Maria della Misericordia Hosp, Stroke Unit, Perugia, Italy
[2] Univ Perugia, Santa Maria della Misericordia Hosp, Div Cardiovasc Med, Perugia, Italy
[3] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Clin & Translat Neurosci Unit, New York, NY USA
[4] Weill Cornell Med, Dept Neurol, New York, NY USA
来源：
STROKE | 2019年 / 50卷 / 04期
关键词：
dabigatran; embolism; ESUS; rivaroxaban; secondary prevention; RANDOMIZED-TRIAL RATIONALE; DOUBLE-BLIND; PREVENTION; EFFICACY; ASPIRIN; SAFETY;
D O I：
10.1161/STROKEAHA.118.024160
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1032 / 1033
页数：2
相关论文
共 50 条
  • [1] Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial
    Del Brutto, Victor J.
    Diener, Han-Christoph
    Easton, J. Donald
    Granger, Christopher B.
    Cronin, Lisa
    Kleine, Eva
    Grauer, Claudia
    Brueckmann, Martina
    Toyoda, Kazunori
    Schellinger, Peter D.
    Lyrer, Philippe
    Molina, Carlos A.
    Chutinet, Aurauma
    Bladin, Christopher F.
    Estol, Conrado J.
    Sacco, Ralph L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (11):
  • [2] Dabigatran Treatment in Embolic Stroke of Undetermined Source and Elevated Biomarkers: The RE-SPECT ESUS Trial
    Skaistis, Joel
    George, Julie
    Diener, Hans Christoph
    CJC OPEN, 2023, 5 (03) : 256 - 257
  • [3] Predictors of atrial fibrillation in patients with embolic stroke of undetermined source: an analysis of the RE-SPECT ESUS trial
    Granger, C. B.
    Sacco, R. L.
    Easton, J. D.
    Meyerhoff, J.
    Cronin, L.
    Kleine, E.
    Grauer, C.
    Bahit, M. C.
    Brueckmann, M.
    Diener, H. -C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 92 - 92
  • [4] Antithrombotic Treatment of Embolic Stroke of Undetermined Source RE-SPECT ESUS Elderly and Renally Impaired Subgroups
    Diener, Hans-Christoph
    Sacco, Ralph L.
    Easton, J. Donald
    Granger, Christopher B.
    Bar, Michal
    Bernstein, Richard A.
    Brainin, Michael
    Brueckmann, Martina
    Cronin, Lisa
    Donnan, Geoffrey
    Gdovinova, Zuzana
    Grauer, Claudia
    Kleine, Eva
    Kleinig, Timothy J.
    Lyrer, Philippe
    Martins, Sheila
    Meyerhoff, Juliane
    Milling, Truman
    Pfeilschifter, Waltraud
    Poli, Sven
    Reif, Michal
    Rose, David Z.
    Sanak, Daniel
    Schaebitz, Wolf-Ruediger
    STROKE, 2020, 51 (06) : 1758 - 1765
  • [5] RE-SPECT ESUS: DABIGATRAN VERSUS ACETYLSALICYLIC ACID FOR STROKE PREVENTION IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE
    Diener, H. C.
    Sacco, R. L.
    Easton, J. D.
    Granger, C. B.
    Cronin, L.
    Grauer, C.
    Cotton, D.
    Brueckmann, M.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 27 - 27
  • [6] Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale Results From RE-SPECT ESUS
    Diener, Hans-Christoph
    Chutinet, Aurauma
    Easton, J. Donald
    Granger, Christopher B.
    Kleine, Eva
    Marquardt, Lars
    Meyerhoff, Juliane
    Zini, Andrea
    Sacco, Ralph L.
    STROKE, 2021, 52 (03) : 1065 - 1068
  • [7] Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source RE-SPECT ESUS Subgroup Analysis
    Uchiyama, Shinichiro
    Toyoda, Kazunori
    Lee, Byung-Chul
    Liou, Chia-Wei
    Wong, Lawrence Ka Sing
    Grauer, Claudia
    Brueckmann, Martina
    Taniguchi, Atsushi
    Urano, Yasuhisa
    Easton, J. Donald
    STROKE, 2021, 52 (03) : 1069 - 1073
  • [8] Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial
    Bahit, Maria Cecilia
    Sacco, Ralph L.
    Easton, J. Donald
    Meyerhoff, Juliane
    Cronin, Lisa
    Kleine, Eva
    Grauer, Claudia
    Brueckmann, Martina
    Diener, Hans-Christoph
    Lopes, Renato D.
    Brainin, Michael
    Lyrer, Phillippe
    Wachter, Rolf
    Segura, Tomas
    Granger, Christopher B.
    CIRCULATION, 2021, 144 (22) : 1738 - 1746
  • [9] MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL)
    Granger, Christopher B.
    Diener, Hans-Christoph
    Sacco, Ralph
    Easton, J.
    Cronin, Lisa
    Frassdorf, Mandy
    Grauer, Claudia
    Brueckmann, Martina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1757 - 1757
  • [10] Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes
    Granger, Christopher B.
    Diener, Hans-Christoph
    Sacco, Ralph L.
    Easton, J. Donald
    Cronin, Lisa
    Fraessdorf, Mandy
    Grauer, Claudia
    Brueckmann, Martina
    CIRCULATION, 2018, 138 (25) : E768 - E768
12345